Perakakis N, Kalra B, Angelidi A, Kumar A, Gavrieli A, Yannakoulia M, et al. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism. 2022;129:155157 pubmed publisher

Perakakis N, Farr O, Mantzoros C. Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward- and attention-related brain centres in response to visual food cues in adults with obesity: A cross-sectional functional MRI study. Diabetes Obes Metab. 2021;23:1202-1207 pubmed publisher

Kim S, Abbasi F, Nachmanoff C, Stefanakis K, Kumar A, Kalra B, et al. Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial. Diabetes Obes Metab. 2021;23:489-498 pubmed publisher

Shah A, Dodson W, Kris Etherton P, Kunselman A, Stetter C, Gnatuk C, et al. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021;106:108-119 pubmed publisher

Polyzos S, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis A, et al. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020;105: pubmed publisher

Tuccinardi D, Farr O, Upadhyay J, Oussaada S, Klapa M, Candela M, et al. Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology study. Diabetes Obes Metab. 2019;21:2086-2095 pubmed publisher

Tuccinardi D, Farr O, Upadhyay J, Oussaada S, Mathew H, Paschou S, et al. Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial. Diabetes Obes Metab. 2019;21:1487-1492 pubmed publisher

Fothergill L, Ringuet M, Sioras E, Hunne B, Fazio Coles T, Martins P, et al. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat. Cell Tissue Res. 2019;375:359-369 pubmed publisher